Form 4: GoHealth CEO Vijay Kotte Reports Stock and Option Grants in Form 4 Filing

GoHealth's CEO, Vijay Kotte, reported the acquisition of restricted stock units and stock options in a recent Form 4 filing with the SEC.

Summary

• Vijay Kotte, CEO of GoHealth, Inc., filed a Form 4 with the SEC on April 3, 2024.
• The filing reports a transaction date of April 1, 2024.
• Kotte acquired 166,666 shares of Class A Common Stock as restricted stock units.
• These restricted stock units vest in three annual installments starting April 1, 2025.
• Kotte also acquired 83,333 stock options with an exercise price of $10.65.
• These options also vest in three annual installments starting April 1, 2025, and expire on April 1, 2034.
• The filing also notes that Kotte owns 821,582 shares of Class A Common Stock directly, including 1,286 shares purchased through the Employee Stock Purchase Plan on December 31, 2023.
• Bradley Burd is acting as Attorney-in-fact for Vijay Kotte.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The grants themselves are a positive sign of aligning management interests, but the filing itself is simply a procedural requirement.

Positives

• The grant of restricted stock units and stock options to the CEO aligns his interests with the long-term performance of the company.
• The vesting schedule encourages continued service and commitment from the CEO.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

• Stock option and restricted stock unit grants are common compensation practices for executives in publicly traded companies, including GoHealth's competitors in the health insurance marketplace.
• Companies like eHealth, Inc. (EHTH) and SelectQuote, Inc. (SLQT) also utilize similar equity-based compensation to incentivize their leadership teams.

Stakeholder Impact

• The equity grants align the CEO's interests with those of shareholders, potentially driving long-term value creation.

Key Dates